{
  "id": "5a8712af61bb38fb24000002",
  "type": "factoid",
  "question": "What is the link between psoriatic arthritis and depression",
  "ideal_answer": "Depression Is Associated with an Increased Risk of Psoriatic Arthritis among Patients with Psoriasis. ",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22556134",
    "http://www.ncbi.nlm.nih.gov/pubmed/24800325",
    "http://www.ncbi.nlm.nih.gov/pubmed/28212760",
    "http://www.ncbi.nlm.nih.gov/pubmed/24692521",
    "http://www.ncbi.nlm.nih.gov/pubmed/28052180",
    "http://www.ncbi.nlm.nih.gov/pubmed/26178281",
    "http://www.ncbi.nlm.nih.gov/pubmed/28237512",
    "http://www.ncbi.nlm.nih.gov/pubmed/26882216",
    "http://www.ncbi.nlm.nih.gov/pubmed/21794775",
    "http://www.ncbi.nlm.nih.gov/pubmed/26186277",
    "http://www.ncbi.nlm.nih.gov/pubmed/28733473",
    "http://www.ncbi.nlm.nih.gov/pubmed/25161652",
    "http://www.ncbi.nlm.nih.gov/pubmed/22015150",
    "http://www.ncbi.nlm.nih.gov/pubmed/21317853",
    "http://www.ncbi.nlm.nih.gov/pubmed/27221798"
  ],
  "snippets": [
    {
      "text": "Depression Is Associated with an Increased Risk of Psoriatic Arthritis among Patients with Psoriasis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28237512",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "merging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28212760",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis?",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28733473",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To investigate the predictive value of baseline depression/anxiety on the likelihood of achieving joint remission in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) as well as the associations between baseline depression/anxiety and the components of the remission criteria at follow-up.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28733473",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Rate of depression was higher in patients with PsA compared to non-PsA patients. The rate of suicidal behaviors was similar between the two cohorts.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26882216",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Over the past decade, multiple studies have shown that not only is there an association between psoriasis and psoriatic arthritis, depression, and substance abuse, but psoriasis patients also have a higher incidence of obesity, diabetes, heart disease and stroke.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21317853",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Psoriasis is a chronic disease that affects more than the skin. It has an impact on every facet of an individual's life and is associated with numerous comorbidities, such as obesity, diabetes, cardiovascular disease, psoriatic arthritis, metabolic syndrome, squamous cell carcinoma, lymphoma, depression, anxiety and other immune-related conditions, such as Crohn's disease. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24800325",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We found an increased risk of depression in US women with psoriasis compared with those without psoriasis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26186277",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The impact of comorbidities (psoriatic arthritis, cardiovascular disease, diabetes, and depression) on relative importance scores of each attribute was assessed by analyses of varianc",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22015150",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Furthermore, obesity and psychological diseases such as depression and anxiety disorders are linked with psoriasis and play a\u00a0central role in its management.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27221798",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Recommendations were synthesized into 19 final recommendations ranging mainly from grade C to D, and relating to a large spectrum of comorbidities observed in clinical practice: CVD, obesity, osteoporosis, depression, infections, and cancer. Level of agreement ranged from 80.9% to 95.8%.CONCLUSION: These practical evidence-based recommendations can guide management of comorbidities in patients with RA, PsA, and PsO and optimize outcome",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26178281",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22556134",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " The rate of depression and anxiety is significantly higher in patients with PsA than in those with PsC. Depression and anxiety are associated with disease-related factors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24692521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The prevalence of anxiety symptoms and the prevalence of depression symptoms are high among patients suffering psoriatic arthritis in the studied population.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21794775",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Psoriasis (Pso) is a common chronic cutaneous inflammatory disease involving the skin that is associated with serious comorbidities. Comorbidities in Pso include psoriatic arthritis (PsA), reduced quality of life, malignancy, depression, but also a constellation of associated conditions that enhance the cardiovascular (CV) risk. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25161652",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dermatologists and primary care providers share roles in screening for associated comorbidities (including cardiovascular disorders, chronic kidney disease, Crohn disease, dyslipidemia, diabetes mellitus/insulin resistance, depression, metabolic syndrome, obesity, and psoriatic arthritis),",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28052180",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.disease-ontology.org/api/metadata/DOID:9008",
    "https://meshb.nlm.nih.gov/record/ui?ui=D015535"
  ],
  "exact_answer": "comorbidity"
}